ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
3
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,567
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Lenalidomide and rituximab for untreated indolent non-Hodgkin's lymphoma
Author(s):
NH Fowler MP
,
L Kwak
,
F Hagemeister
Publication date:
2009
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Primate Tool Use
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
2,567
A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma
Authors:
Markus Raderer
,
Richard Greil
,
Thomas Melchardt
…
Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study
Authors:
S. Pozzi-Langhi
,
M Gentile
,
S. Sacchi
Daratumumab, lenalidomide, and dexamethasone (DRd) versus lenalidomide and dexamethasone (Rd) in relapsed or refractory multiple myeloma (RRMM): updated efficacy and safety analysis of POLLUX [abstract]
Authors:
Dimopoulos MA
See all similar